Achillion Pharmaceuticals

Pipeline

Achillion has drug candidates that are poised to meet patient needs



Achillion employs a rational, intensely iterative approach to drug discovery and development, while applying market insight throughout the process to identify the greatest patient and clinical needs, the most efficient development pathways, and the best commercial opportunities for its new medicines.

ACH-4471, ACH-5228, and ACH-5548 are investigational compounds. Their safety and efficacy have not been established.

Achillion Corporate Overview (June)
Adobe PDF (2 MB)